Claims Analysis
Total Claims: 51
Claim 1
Independent Claim
345 words
An x-ray contrast composition designed for depositing a thin, flexible film membrane onto the mucosal lining of the nutrient absorbing inner surface of the intestine of a patient to form a barrier between said nutrient absorbing inner surface and the content of said intestine, said flexible film membrane to remain bound to said muscosal lining until eliminated by normal cell turnover comprising based on w/v: (a) of from about 0.001 to about 15% of a polymeric material capable of forming a film membrane on the gastrointestinal tract in the pH range of from about 5 to about 8, and polymeric material being selected from the group consisting of anionic polymers carrying negative charges in the ionized form, cationic polymers carrying positive charges in the ionized form, and neutral polymers, said neutral polymers having atoms containing polarizable electrons thereon selected from the group consisting of oxygen, nitrogen, sulfur, fluoride, chloride, bromide and iodide in combination with (b) of from about 0.001 to about 15% of a divalent cation to potentiate the binding of said flexible film membrane to said mucusoal lining selected from the group consisting of Ca ++ , Mg ++ , Zn ++ and Ba ++ ; and c) of from about 0.001 to about 75% of an x-ray contrast producing agent having the formula, or a pharmaceutically acceptable salt thereof ##STR22## wherein Z=H, halo, C 1 -C 20 alkyl, cycloalkyl, lower alkoxy, alkoxycarbonyl, cyano, where the alkyl and cycloalkyl groups can be substituted with halogen or halo-lower-alkyl groups; R=C 1 -C 25 alkyl, cycloalkyl, ##STR23## or halo-lower-alkyl, each of which may be optionally substituted with halo, fluoro-lower-alkyl, lower-alkoxy, lower-alkoxy carbonyl or lower-alkoxy-carbonyloxy (CR 1 R 2 ) p --(CR 3 =CR 4 ) m Q, or (CR 1 R 2 ) p --C.tbd.C--Q; R 1 , R 2 , R 3 and R 4 are independently H or lower-alkyl, optionally substituted with halo; x is 1-4; n is 1-4; m is 1-15; p is 1-20; and Q is H, lower-alkyl, lower-alkenyl, lower-alkynyl, lower-alkylene, aryl, or aryl-lower alkyl in an aqueous, pharmaceutically acceptable carrier.
Claim 2
Dependent Claim
345 words
An x-ray contrast composition designed for depositing a thin, flexible film membrane onto the mucosal lining of the nutrient absorbing inner surface of the intestine of a patient to form a barrier between said nutrient absorbing inner surface and the content of said intestine, said flexible film membrane to remain bound to said muscosal lining until eliminated by normal cell turnover comprising based on w/v: (a) of from about 0.001 to about 15% of a polymeric material capable of forming a film membrane on the gastrointestinal tract in the pH range of from about 5 to about 8, and polymeric material being selected from the group consisting of anionic polymers carrying negative charges in the ionized form, cationic polymers carrying positive charges in the ionized form, and neutral polymers, said neutral polymers having atoms containing polarizable electrons thereon selected from the group consisting of oxygen, nitrogen, sulfur, fluoride, chloride, bromide and iodide in combination with (b) of from about 0.001 to about 15% of a divalent cation to potentiate the binding of said flexible film membrane to said mucusoal lining selected from the group consisting of Ca ++ , Mg ++ , Zn ++ and Ba ++ ; and c) of from about 0.001 to about 75% of an x-ray contrast producing agent having the formula, or a pharmaceutically acceptable salt thereof ##STR22## wherein Z=H, halo, C 1 -C 20 alkyl, cycloalkyl, lower alkoxy, alkoxycarbonyl, cyano, where the alkyl and cycloalkyl groups can be substituted with halogen or halo-lower-alkyl groups; R=C 1 -C 25 alkyl, cycloalkyl, ##STR23## or halo-lower-alkyl, each of which may be optionally substituted with halo, fluoro-lower-alkyl, lower-alkoxy, lower-alkoxy carbonyl or lower-alkoxy-carbonyloxy (CR 1 R 2 ) p --(CR 3 =CR 4 ) m Q, or (CR 1 R 2 ) p --C.tbd.C--Q; R 1 , R 2 , R 3 and R 4 are independently H or lower-alkyl, optionally substituted with halo; x is 1-4; n is 1-4; m is 1-15; p is 1-20; and Q is H, lower-alkyl, lower-alkenyl, lower-alkynyl, lower-alkylene, aryl, or aryl-lower alkyl in an aqueous, pharmaceutically acceptable carrier.
Claim 3
Dependent Claim
26 words
The composition according to claim 1 wherein said x-ray contrast agent is selected from the group consisting of- bis-(4-iodophenyl) ether of polyethylene-glycol-400, 1,8-Bis-O-(2,4,6-triiodophenyl)-tripropylene glycol and 1,11-bis-(2,4,6-triiodophenoxy)-3,6,9-trioxaundecane.
Claim 4
Dependent Claim
27 words
The composition according to claim 1 wherein said x-ray contrast agent is selected from the group consisting of: 1,2-bis-(2,4,6-Triiodophenoxy)-ethane, bis-0-(2,4,6-triiodophenyl) ether of polyethylene glycol 40 and 1-(3-iodophenoxy)-3,6,9-trioxadecane.
Claim 5
Dependent Claim
22 words
The composition according to claim 1 wherein said x-ray contrast agent is selected from the group consisting of: 1,3-Bis-(2,4,6-Triiodophenoxy)-butane, 1-(3-iodophenoxy)-6-(2,4,6-triiodophenoxy)hexane and 1,12-Bis-(2,4,6-Triiodophenoxy)-dodecane.
Claim 6
Dependent Claim
34 words
The x-ray contrast composition of claim 1 wherein said polymeric material is anionic having the formula: ##STR24## wherein R is the polymeric chain; ##STR25## are anionic ligands; and M ++ is a divalent cation.
Claim 7
Dependent Claim
78 words
The x-ray contrast composition of claim 5 wherein said anionic polymeric material is a sulfated polysaccharide having the formula: ##STR26## wherein R is ______________________________________
3,6-anhydro-D-galactose linked
(kappa carrageenan)
through C-4 to D-galactose;
α-D-galactose units (1-3) linked;
(lambda carrageenan)
D-galactose (iota carrageenan)
3,6-anhydro-D-galactose;
D-galactose (Agar--Agar)
3,6-anhydro-L-galactose:
D-galactose (Furcellaren)
3,6-anhydro-D-galactose;
D-glucopyranose; (Laminarin sulfate)
Galactan; and (Galactan sulfate)
Galactosamino-glucuronans
(Chondroitin sulfates);
______________________________________ and M ++ is Mg ++ , Ca ++ , Zn ++ , Ba ++ or a mixture thereof.
Claim 8
Dependent Claim
54 words
The x-ray contrast composition of claim 5 wherein said anionic polymeric material is a carboxylated polysaccharide having the formula: ##STR27## wherein R is ______________________________________
D-galacturonoglycan; and
(Pectin)
anhydro-D-mannuronic acid
and anhydro-L-guluronic acid
(Algin)
residues; and
______________________________________ M ++ is Mg ++ , Ca ++ , Zn ++ , Ba ++ or a mixture thereof.
Claim 9
Dependent Claim
70 words
The x-ray contrast composition of claim 5 wherein said anionic polymeric material is a cellulose derivative of the formula: ##STR28## wherein H is an anhydroglucose residue; R' is CH 3 , C 2 H 5 or C 3 H 7 ; R" is CH 3 or C 2 H 5 ; and M ++ is Mg ++ , Ca ++ , Zn ++ , Ba ++ or a mixture thereof.
Claim 10
Dependent Claim
29 words
The X-ray contract composition of claim 8 wherein said cellulose derivative is selected from the group consisting of sodium ethylcellulose sulfate, sodium cellulose acetate sulfate and sodium carboxymethyl cellulose.
Claim 11
Dependent Claim
51 words
The x-ray contrast composition of claim 1 wherein said anionic polymeric material is a sulfated, sulfonated or carboxylated synthetic polymer having the formula: ##STR29## wherein R is an aliphatic or aromatic hydrocarbon; and M ++ is Mg ++ , Ca ++ , Zn ++ , Ba ++ or a mixture thereof.
Claim 12
Dependent Claim
27 words
The x-ray contrast composition of claim 1 wherein said polymeric material is cationic selected from the group consisting of dermatan sulfate, keratosulfate, hyaluronic acid, heparin and chitin.
Claim 13
Dependent Claim
14 words
The x-ray contrast composition of claim 1 wherein said polymeric material is a polysaccharide.
Claim 14
Dependent Claim
31 words
The x-ray contrast composition of claim 12 wherein said polysaccharide is selected from the group consisting of starch, glycogen, glucan, fructans, mannans, galactomannans, flucomannas, galactans, xylans, glycuranans, dextran and starch amylose.
Claim 15
Dependent Claim
15 words
The x-ray contrast composition of claim 1 wherein said polymeric material is a cellulose derivative.
Claim 16
Dependent Claim
25 words
The x-ray contrast composition of claim 14 wherein said cellulose derivative is selected from the group consisting of methylcellulose, hydroxyethyl cellulose, ethylhydroxyethyl and hydroxypropyl cellulose.
Claim 17
Dependent Claim
20 words
The x-ray contrast composition of claim 1 wherein said polymeric material is polyvinylpyrrolidone, polyvinyl alcohol or an ethylene oxide polymer.
Claim 18
Dependent Claim
16 words
The x-ray contrast composition of claim 1 wherein said pharmaceutical carrier contains at least one surfactant.
Claim 19
Dependent Claim
12 words
The x-ray contrast formulation of claim 17 wherein said surfactant is cationic.
Claim 20
Dependent Claim
12 words
The x-ray contrast formulation of claim 17 wherein said surfactant is anionic.
Claim 21
Dependent Claim
12 words
The x-ray contrast formulation of claim 17 wherein said surfactant is zwitterionic.
Claim 22
Dependent Claim
12 words
The x-ray contrast formulation of claim 17 wherein said surfactant is nonionic.
Claim 23
Dependent Claim
27 words
The x-ray contrast formulation of claim 18 wherein said cationic surfactant is selected from the group consisting of cetyl trimethyl ammonium bromide and dodecyl dimethyl ammonium bromide.
Claim 24
Dependent Claim
34 words
The x-ray contrast formulation of claim 19 wherein said anionic surfactant is selected form the group consisting of sodium lauryl sulfate, sodium heptadecyl sulphate, an alkyl benzene sulphonic acid, sodium butylnaphthalene sulfonate and sulphosuccinate.
Claim 25
Dependent Claim
39 words
The x-ray contrast formulation of claim 1 wherein said nonionic surfactant is selected from the group consisting of carboxylic esters. carboxylic amides, ethoxylated alkylphenol and ethoxylated aliphatic alcohols, sorbitan esters, polyoxyethylene alkyl ethers and polyoxyethylene sorbitan fatty acid esters.
Claim 26
Dependent Claim
42 words
A method of carrying out x-ray examination of the gastrointestinal tract of a patient, said method comprises the oral or rectal administration to the patient the x-ray contrast composition of claim 1 and examining said gastrointestinal tract by an x-ray producing apparatus.
Claim 27
Dependent Claim
24 words
The method of claim 25 wherein said contrast agent is selected from the group consisting of: bis-(4-iodophenyl) ether of polyethylene-glycol-400, 1,8-Bis-O-(2,4,6-triiodophenyl)-tripropylene glycol and 1,11-bis-(2,4,6-triiodophenoxy)-3,6,9-trioxanundecane.
Claim 28
Dependent Claim
24 words
The method of claim 25 wherein said contrast agent is selected from the group consisting of: 1,2-bis-(2,4,6-Triiodophenoxy)-ethane, bis-O-(2,4,6-triiodophenyl)ether of polyethylene glycol 40 and 1-(3-Iodophenoxy)-3,6,9-trioxadecane.
Claim 29
Dependent Claim
20 words
The method of claim 25 wherein said contrast agent is selected from the group consisting of: 1,3-Bis-(2,4,6-Triiodophenoxy)-butane, 1-(3-iodophenoxy)-6-(2,4,6-triiodophenoxy)hexane and 1,12-Bis-(2,4,6-Triiodophenoxy)-dodecane.
Claim 30
Dependent Claim
38 words
The method of claim 25 wherein the amount of contrast agent administered to said patient is in the range of from about 0.1 to about 16.0 g iodine/kg body weight for regular x-ray visualization of the gastrointestinal tract.
Claim 31
Dependent Claim
39 words
The method of claim 25 wherein the amount of contrast agent administered to said patient will be in the range of from about 1 to about 600 mg iodine/kg body weight for CT scan visualization of the gastrointestinal tract.
Claim 32
Dependent Claim
15 words
The method of claim 25 wherein said pharmaceutically acceptable carrier contains at least one surfactant.
Claim 33
Dependent Claim
10 words
The method of claim 31 wherein said surfactant is cationic.
Claim 34
Dependent Claim
10 words
The method of claim 31 wherein said surfactant is anionic.
Claim 35
Dependent Claim
10 words
The method of claim 31 wherein said surfactant is zwitterionic.
Claim 36
Dependent Claim
10 words
The method of claim 31 wherein said surfactant is nonionic.
Claim 37
Dependent Claim
25 words
The method of claim 32 wherein said cationic surfactant is selected from the group consisting of cetyl trimethyl ammonium bromide and dodecyl dimethyl ammonium bromide.
Claim 38
Dependent Claim
31 words
The method of claim 33 wherein said anionic surfactant is selected from the group consisting of sodium lauryl sulfate; sodium heptadecyl sulphate, an alkyl benzenesulphonic acid, sodium butylnaphthalene sulfonate and sulphosuccinates.
Claim 39
Dependent Claim
39 words
The method of claim 35 wherein said nonionic surface active agent is selected from the group consisting of carboxylic esters, carboxylic amides, ethoxylated alkylphenols and ethoxylated aliphatic alcohols, sorbitan esters, polyoxyethylene alkyl ethers and polyoxyethylene sorbitan fatty acid esters.
Claim 40
Dependent Claim
28 words
The method of claim 25 wherein said polymeric material is anionic having the formula: ##STR30## wherein R is the polymeric chain; ##STR31## M ++ is a divalent cation.
Claim 41
Dependent Claim
76 words
The method of claim 39 wherein said anionic polymeric material is a sulfated polysaccharide having the formula: ##STR32## wherein R is ______________________________________
3,6-anhydro-D-galactose linked
(kappa carrageenan)
through C-4 to D-galactose;
α-D-galactose units (1-3) linked;
(lambda carrageenan)
D-galactose (iota carrageenan)
3,6-anhydro-D-galactose;
D-galactose (Agar--Agar)
3,6-anhydro-L-galactose;
D-galactose (Furcellaren)
3,6-anhydro-D-galactose;
D-glucopyranose; (Laminarin sulfate)
Galactan; and (Galactan sulfate)
Galactosamino-glucuronans
(Chondroitin sulfates);
and
______________________________________ M ++ is Mg ++ , Ca ++ , Zn ++ , Ba ++ or a mixture thereof.
Claim 42
Dependent Claim
52 words
The method of claim 39 wherein said anionic polymeric material is a carboxylated polysaccharide having the formula: ##STR33## wherein R is ______________________________________
D-galacturonoglycan; and
(Pectin)
anhydro-D-mannuronic acid
and anhydro-L-guluronic acid
(Algin)
residues; and
______________________________________ M ++ is Mg ++ , Ca ++ , Zn ++ , Ba ++ or a mixture thereof.
Claim 43
Dependent Claim
68 words
The method of claim 39 wherein said anionic polymeric material is a cellulose derivative of the formula: ##STR34## wherein R is an anhydroglucose residue; R' is CH 3 , C 2 H 5 or C 3 H 7 ; R" is CH 3 or C 2 H 5 ; and M ++ is Mg ++ , Ca ++ , Zn ++ , Ba ++ or a mixture thereof.
Claim 44
Dependent Claim
27 words
The method of claim 42 wherein said cellulose derivative is selected from the group consisting of sodium ethylcellulose sulfate, sodium cellulose acetate sulfate and sodium carboxymethyl cellulose.
Claim 45
Dependent Claim
49 words
The method of claim 25 wherein said anionic polymeric material is a sulfated, sulfonated or carboxylated synthetic polymer having the formula: ##STR35## wherein R is an aliphatic or aromatic hydrocarbon; and M ++ is Mg ++ , Ca ++ , Zn ++ , B ++ or a mixture thereof.
Claim 46
Dependent Claim
25 words
The method of claim 25 wherein said polymeric material is cationic selected from the group consisting of: dermatan sulfate, keratosulfate, hyaluronic acid, heparin and chitin.
Claim 47
Dependent Claim
12 words
The method of claim 25 wherein said polymeric material is a polysaccharide.
Claim 48
Dependent Claim
29 words
The method of claim 46 wherein said polysaccharide is selected from the group consisting of starch, glycogen, glucan, fructans, mannans, galactomannans, fluocmannas, galactans, xylans, glycuranans, dextran and starch amylose.
Claim 49
Dependent Claim
13 words
The method of claim 25 wherein said polymeric material is a cellulose derivative.
Claim 50
Dependent Claim
23 words
The method of claim 48 wherein said cellulose derivative is selected from the group consisting of methylcellulose, hydroxyethyl cellulose, ethylhydroxyethyl and hydroxypropyl cellulose.
Claim 51
Dependent Claim
18 words
The method of claim 25 wherein said polymeric material is polyvinylpyrrolidone, polyvinyl alcohol or an ethylene oxide polymer.